المؤلفون: Wang Z; Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, P.R. China., Zhang J; Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, P.R. China., Xia T; Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, P.R. China., He R; Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, P.R. China., Yan F; Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, P.R. China.

المصدر: Journal of biopharmaceutical statistics [J Biopharm Stat] 2024 Jul 03; Vol. 34 (4), pp. 582-595. Date of Electronic Publication: 2023 Jul 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9200436 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5711 (Electronic) Linking ISSN: 10543406 NLM ISO Abbreviation: J Biopharm Stat Subsets: MEDLINE

مواضيع طبية MeSH: Bayes Theorem* , Clinical Trials, Phase I as Topic*/statistics & numerical data , Clinical Trials, Phase I as Topic*/methods , Clinical Trials, Phase II as Topic*/statistics & numerical data , Clinical Trials, Phase II as Topic*/methods , Dose-Response Relationship, Drug* , Research Design*/statistics & numerical data , Computer Simulation*, Humans ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Logistic Models ; Neoplasms/drug therapy ; Linear Models ; Models, Statistical

المؤلفون: Sharma P; Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, Kansas, USA., Phadnis MA; Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, Kansas, USA.

المصدر: Journal of biopharmaceutical statistics [J Biopharm Stat] 2024 Jul 03; Vol. 34 (4), pp. 596-611. Date of Electronic Publication: 2023 Aug 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9200436 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5711 (Electronic) Linking ISSN: 10543406 NLM ISO Abbreviation: J Biopharm Stat Subsets: MEDLINE

مواضيع طبية MeSH: Clinical Trials, Phase II as Topic*/statistics & numerical data , Clinical Trials, Phase II as Topic*/methods , Stochastic Processes*, Humans ; Research Design/statistics & numerical data ; Sample Size ; Proportional Hazards Models ; Time Factors ; Computer Simulation ; Treatment Outcome ; Bayes Theorem ; Endpoint Determination/statistics & numerical data ; Endpoint Determination/methods

المؤلفون: Cao S; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina., Jung SH; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.

المصدر: Statistics in medicine [Stat Med] 2024 May 30; Vol. 43 (12), pp. 2359-2367. Date of Electronic Publication: 2024 Apr 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 8215016 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0258 (Electronic) Linking ISSN: 02776715 NLM ISO Abbreviation: Stat Med Subsets: MEDLINE

مواضيع طبية MeSH: Randomized Controlled Trials as Topic*/methods , Randomized Controlled Trials as Topic*/statistics & numerical data , Clinical Trials, Phase II as Topic*/methods , Clinical Trials, Phase II as Topic*/statistics & numerical data, Humans ; Confidence Intervals ; Odds Ratio ; Models, Statistical ; Computer Simulation ; Research Design

المؤلفون: Yang P; Department of Statistics, Rice University, Houston, Texas, USA.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Li D; Bristol Myers Squibb, Seattle, Washington, USA., Lin R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Huang B; Pfizer Inc., New York, New York, USA., Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

المصدر: Statistics in medicine [Stat Med] 2024 Jul 10; Vol. 43 (15), pp. 2972-2986. Date of Electronic Publication: 2024 May 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 8215016 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0258 (Electronic) Linking ISSN: 02776715 NLM ISO Abbreviation: Stat Med Subsets: MEDLINE

مواضيع طبية MeSH: Maximum Tolerated Dose* , Randomized Controlled Trials as Topic* , Clinical Trials, Phase II as Topic*/methods , Research Design* , Computer Simulation* , Algorithms*, Sample Size ; Humans ; Dose-Response Relationship, Drug ; United States ; United States Food and Drug Administration

المؤلفون: Moyer H; From the Department of Equity, Ethics and Policy (H.M., R.M., K.V., M.M., J. Kimmelman), McGill University, Montreal, Quebec, Canada; Penn Memory Center (J. Karlawish), University of Pennsylvania, Philadelphia; Clinical Trials Unit (E.A.), Kennedy Krieger Institute, Baltimore, MD; Departments of Psychiatry and Behavioral Sciences and Neurology, Keck School of Medicine (L.S.), and L. Davis School of Gerontology (L.S.), University of Southern California, Los Angeles., Mellett R; From the Department of Equity, Ethics and Policy (H.M., R.M., K.V., M.M., J. Kimmelman), McGill University, Montreal, Quebec, Canada; Penn Memory Center (J. Karlawish), University of Pennsylvania, Philadelphia; Clinical Trials Unit (E.A.), Kennedy Krieger Institute, Baltimore, MD; Departments of Psychiatry and Behavioral Sciences and Neurology, Keck School of Medicine (L.S.), and L. Davis School of Gerontology (L.S.), University of Southern California, Los Angeles., Vigneault K; From the Department of Equity, Ethics and Policy (H.M., R.M., K.V., M.M., J. Kimmelman), McGill University, Montreal, Quebec, Canada; Penn Memory Center (J. Karlawish), University of Pennsylvania, Philadelphia; Clinical Trials Unit (E.A.), Kennedy Krieger Institute, Baltimore, MD; Departments of Psychiatry and Behavioral Sciences and Neurology, Keck School of Medicine (L.S.), and L. Davis School of Gerontology (L.S.), University of Southern California, Los Angeles., McKeown M; From the Department of Equity, Ethics and Policy (H.M., R.M., K.V., M.M., J. Kimmelman), McGill University, Montreal, Quebec, Canada; Penn Memory Center (J. Karlawish), University of Pennsylvania, Philadelphia; Clinical Trials Unit (E.A.), Kennedy Krieger Institute, Baltimore, MD; Departments of Psychiatry and Behavioral Sciences and Neurology, Keck School of Medicine (L.S.), and L. Davis School of Gerontology (L.S.), University of Southern California, Los Angeles., Karlawish J; From the Department of Equity, Ethics and Policy (H.M., R.M., K.V., M.M., J. Kimmelman), McGill University, Montreal, Quebec, Canada; Penn Memory Center (J. Karlawish), University of Pennsylvania, Philadelphia; Clinical Trials Unit (E.A.), Kennedy Krieger Institute, Baltimore, MD; Departments of Psychiatry and Behavioral Sciences and Neurology, Keck School of Medicine (L.S.), and L. Davis School of Gerontology (L.S.), University of Southern California, Los Angeles., Augustine E; From the Department of Equity, Ethics and Policy (H.M., R.M., K.V., M.M., J. Kimmelman), McGill University, Montreal, Quebec, Canada; Penn Memory Center (J. Karlawish), University of Pennsylvania, Philadelphia; Clinical Trials Unit (E.A.), Kennedy Krieger Institute, Baltimore, MD; Departments of Psychiatry and Behavioral Sciences and Neurology, Keck School of Medicine (L.S.), and L. Davis School of Gerontology (L.S.), University of Southern California, Los Angeles., Schneider L; From the Department of Equity, Ethics and Policy (H.M., R.M., K.V., M.M., J. Kimmelman), McGill University, Montreal, Quebec, Canada; Penn Memory Center (J. Karlawish), University of Pennsylvania, Philadelphia; Clinical Trials Unit (E.A.), Kennedy Krieger Institute, Baltimore, MD; Departments of Psychiatry and Behavioral Sciences and Neurology, Keck School of Medicine (L.S.), and L. Davis School of Gerontology (L.S.), University of Southern California, Los Angeles., Kimmelman J; From the Department of Equity, Ethics and Policy (H.M., R.M., K.V., M.M., J. Kimmelman), McGill University, Montreal, Quebec, Canada; Penn Memory Center (J. Karlawish), University of Pennsylvania, Philadelphia; Clinical Trials Unit (E.A.), Kennedy Krieger Institute, Baltimore, MD; Departments of Psychiatry and Behavioral Sciences and Neurology, Keck School of Medicine (L.S.), and L. Davis School of Gerontology (L.S.), University of Southern California, Los Angeles.

المصدر: Neurology [Neurology] 2024 Jul 09; Vol. 103 (1), pp. e209533. Date of Electronic Publication: 2024 Jun 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE

مواضيع طبية MeSH: Clinical Trials, Phase II as Topic*/methods , Clinical Trials, Phase III as Topic*/methods , Nervous System Diseases*/drug therapy , Nervous System Diseases*/epidemiology, Humans ; Drug Development/methods ; Prevalence

المؤلفون: Giovannoni G; The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: g.giovannoni@qmul.ac.uk., Hawkes CH; The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK., Lechner-Scott J; The University of Newcastle, Australia., Levy M; Massachusetts General Hospital and Harvard Medical School, Massachusetts, USA., Yeh EA; Department of Paediatrics, Dalla Lana School of Public Health, University of Toronto., Pepper G; Shift.ms, Platform, New Station Street, LS1 4JB, United Kingdom., Schmierer K; The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK.

المصدر: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Jul; Vol. 87, pp. 105698. Date of Electronic Publication: 2024 May 31.

نوع المنشور: Journal Article; Editorial

بيانات الدورية: Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Sclerosis*/drug therapy , Multiple Sclerosis*/therapy , Clinical Trials, Phase II as Topic*, Humans ; Immunologic Factors/therapeutic use

المؤلفون: Metts J; Sarcoma Department, Moffitt Cancer Center, Tampa, Florida, USA.; Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St Petersburg, Florida, USA., Xue W; Department of Biostatistics, University of Florida, Gainesville, Florida, USA., Gao Z; Department of Biostatistics, University of Florida, Gainesville, Florida, USA., Oberoi S; Department of Pediatric Hematology/Oncology, CancerCare Manitoba, Winnipeg, Manitoba, Canada., Weiss AR; Department of Pediatrics, Maine Medical Center, Portland, Maine, USA., Venkatramani R; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Harrison DJ; Department of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

المصدر: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Jul; Vol. 71 (7), pp. e31009. Date of Electronic Publication: 2024 Apr 16.

نوع المنشور: Journal Article; Clinical Trial, Phase II

بيانات الدورية: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Rhabdomyosarcoma*/mortality , Rhabdomyosarcoma*/drug therapy , Rhabdomyosarcoma*/therapy , Rhabdomyosarcoma*/pathology , Clinical Trials, Phase II as Topic* , Neoplasm Recurrence, Local*/pathology , Neoplasm Recurrence, Local*/mortality , Neoplasm Recurrence, Local*/drug therapy, Humans ; Female ; Male ; Child ; Retrospective Studies ; Child, Preschool ; Adolescent ; Infant ; Survival Rate ; Prognosis ; Follow-Up Studies

المؤلفون: Bourillon A; Department of Urology, University of Rennes, Rennes, France., Bensalah K; Department of Urology, University of Rennes, Rennes, France. Electronic address: karim.bensalah@chu-rennes.fr.

المصدر: European urology [Eur Urol] 2024 Jul; Vol. 86 (1), pp. 76. Date of Electronic Publication: 2024 Mar 26.

نوع المنشور: Comment; Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

مواضيع طبية MeSH: Kidney Neoplasms*/surgery , Kidney Neoplasms*/pathology , Radiosurgery*/methods , Clinical Trials, Phase II as Topic* , Carcinoma, Renal Cell*/surgery , Carcinoma, Renal Cell*/radiotherapy, Humans

المؤلفون: Yu P; Department of Urology, Shengjing Hospital of China Medical University, Shenyang, 110004, China., Zhu C; Department of Family Medicine, Shengjing Hospital of China Medical University, Shenyang, 110004, China., You X; Department of Urology, Shengjing Hospital of China Medical University, Shenyang, 110004, China.; Department of Urology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, 443002, China.; Department of Urology, Yichang Central People's Hospital, Yichang, 443002, China., Gu W; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, 110004, China., Wang X; Department of Urology, Shengjing Hospital of China Medical University, Shenyang, 110004, China., Wang Y; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, 110004, China. wangyuan19830711@126.com., Bu R; Department of Urology, Shengjing Hospital of China Medical University, Shenyang, 110004, China. burg1972@hotmail.com., Wang K; Department of Urology, Shengjing Hospital of China Medical University, Shenyang, 110004, China. wang.kefeng@hotmail.com.

المصدر: Cell death & disease [Cell Death Dis] 2024 Jun 19; Vol. 15 (6), pp. 433. Date of Electronic Publication: 2024 Jun 19.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE

مواضيع طبية MeSH: Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/pharmacology , Urogenital Neoplasms*/drug therapy , Urogenital Neoplasms*/immunology , Urogenital Neoplasms*/pathology , Immunoconjugates*/therapeutic use , Immunoconjugates*/pharmacology , Clinical Trials, Phase II as Topic*, Humans ; Clinical Trials, Phase III as Topic

المؤلفون: Martin E; Institut de Cancérologie de l'Ouest, F 49055 Angers, France., Le Malicot K; Fédération Francophone de Cancérologie Digestive (FFCD), EPICAD INSERM LNC-UMR 1231, University of Burgundy, F 21078 Dijon, France., Guérin-Charbonnel C; Institut de Cancérologie de l'Ouest, F 49055 Angers, France.; CRCI2NA, INSERM U1307, CNRS UMR6075, University of Nantes, F 44000 Nantes, France., Bocquet F; Institut de Cancérologie de l'Ouest, F 49055 Angers, France.; Law and Social Change Laboratory, Faculty of Law and Political Sciences, CNRS UMR 6297, Nantes University, F 44035 Nantes, France., Bouché O; Department of Digestive Oncology, CHU Reims, F 51092 Reims, France., Turpin A; Department of Medical Oncology, University Hospital, F 59000 Lille, France., Aparicio T; Department of Gastroenterology, Saint Louis Hospital, APHP, Université Paris Cité, F 75010 Paris, France., Legoux JL; Department of Hepato-Gastroenterology and Digestive Oncology, Centre Hospitalier Régional, F 45100 Orléans, France., Dahan L; C.H.U. la Timone and Université de la Méditerranée Marseille, F 13005 Marseille, France., Taieb J; Institut du Cancer Paris CARPEM, Gastroenterology and Digestive Oncology Department, APHP Centre-Université Paris Cité, Hôpital Européen G. Pompidou, F 75015 Paris, France.; Centre de Recherche des Cordeliers, INSERM, CNRS, Sorbonne Université, USPC, Université de Paris, Université Paris Cité, F 75006 Paris, France., Lepage C; Department of HGE & Digestive Oncology, EPICAD INSERM UMR LNC 1231, University Hospital Dijon, University of Burgundy, F 21078 Dijon, France., Dourthe LM; Service d'Oncologie Médicale, Clinique St Anne, F 67000 Strasbourg, France., Pétorin C; Service d'Oncologie Digestive, CHU Clermont-Ferrand, F 63000 Clermont-Ferrand, France., Bourgeois V; Service d'Oncologie Digestive, Centre Hospitalier de Boulogne sur Mer, F 62321 Boulogne-sur-Mer, France., Raoul JL; Institut de Cancérologie de l'Ouest, F 49055 Angers, France., Seegers V; Institut de Cancérologie de l'Ouest, F 49055 Angers, France.

المصدر: Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Jun 17; Vol. 31 (6), pp. 3513-3528. Date of Electronic Publication: 2024 Jun 17.

نوع المنشور: Journal Article; Systematic Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Clinical Trials, Phase II as Topic*/methods, Humans ; Prognosis ; Randomized Controlled Trials as Topic ; Gastrointestinal Neoplasms/drug therapy ; Research Design ; Digestive System Neoplasms/drug therapy